ABCELLERA BIOLOGICS INC (ABCL)
CA00288U1066 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -175.84M | -146.40M | 158.50M | 153.50M | 118.90M | |||
| Depreciation Amortization | 85.78M | 24.39M | 27.90M | 14.50M | 4.80M | |||
| Income Taxes - Deferred | N/A | 1.96M | -2.10M | -2.00M | 2.10M | |||
| Change In Working Capital | -39.32M | 13.22M | 29.80M | 41.70M | -116.70M | |||
| Other non cash items | 7.19M | 62.94M | 63.30M | 37.00M | 13.50M | |||
| OPERATING CASH FLOW | -120.13M | -43.88M | 277.40M | 244.60M | 22.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -77.17M | -77.51M | -72.70M | -58.50M | -14.70M | |||
| Other Investing Activity | 138.57M | -143.60M | -280.00M | -273.80M | -105.10M | |||
| INVESTING CASH FLOW | 61.40M | -221.11M | -352.60M | -332.20M | -119.80M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | -300.00K | -1.00M | 85.20M | |||
| Stock Issued/Repurchased | 5.57M | 11.59M | 2.80M | 4.60M | 598.50M | |||
| Other Financing Activity | 6.81M | -1.23M | -4.10M | -7.60M | N/A | |||
| FINANCING CASH FLOW | 12.38M | 10.36M | -1.60M | -3.90M | 683.70M | |||
| Exchange Rate Effect | 632.00K | 589.00K | -9.60M | -1.40M | N/A | |||
| CHANGE IN CASH | -45.72M | -254.04M | -86.40M | -92.90M | 586.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -120.13M | -43.88M | 277.40M | 244.60M | 22.70M | |||
| Capital Expenditure | -77.17M | -77.51M | -72.70M | -58.50M | -14.70M | |||
| FREE CASH FLOW | -197.31M | -121.38M | 204.70M | 186.10M | 8.00M | |||
All data in USD